Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 8-K Event Regulation FD disclosure
  2. 4 Open-market sale President and CDO sold 8,167 shares at an average $1.85 ($15,148)
  3. 4 Open-market sale Chief Regulatory Officer sold 1,097 shares at $1.98 ($2,176)
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 4 Open-market sale CFO & Chief Business Officer sold 14,905 shares at an average $1.97 ($29,436)
  12. 4 Open-market sale Chief Medical Officer sold 10,834 shares at an average $1.96 ($21,277)
  13. 4 Open-market sale Chief Executive Officer sold 47,506 shares at an average $1.98 ($94,176)
  14. 4 Open-market sale Chief Legal Officer & Corp Sec sold 26,668 shares at an average $1.98 ($52,690)
  15. 4 Open-market sale Chief Operating Officer sold 9,318 shares at an average $1.97 ($18,325)
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 5 of 19 · 365 filings